Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q2 2025 Earnings Call Transcript August 12, 2025
Taysha Gene Therapies, Inc. misses on earnings expectations. Reported EPS is $-0.09 EPS, expectations were $-0.07.
Operator: [Operator Instructions] Ladies and gentlemen, good morning, and welcome to Taysha Gene Therapy’s Second Quarter 2025 Earnings Conference Call. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Haleigh Collins, Director, Head of...
